Friday, 23 May 2014

Alemtuzumab long term follow data is published

You have been asking for the Long-term data on Alemtuzumab. No doubt ProfG will post on this newly published data from Cambridge with followup for up to 12 years, good news but its not all good

4 comments:

  1. Could you post the link to the article please?

    ReplyDelete
  2. Great results! But the proportion of secondary autoimmunity is frightening...

    ReplyDelete
  3. can you give a reference please?

    ReplyDelete
  4. Okay you win, my interest is peaked!!! What's the good news, but more importantly whats the not good news, was there progression to secondary progressive on people started earlier?!

    ReplyDelete

Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.